Happy Bobby Bonilla Day: The 57-Year Old Former Met Gets His Annual $1.1 Million Check

Video Duration:

Sports and Business News: 7/1

Happy Bobby Bonilla Day 

In the world of sports, July 1st is known to many fans as "Bobby Bonilla Day." 

On this day, every year from 2011 to 2035, the New York Mets will pay Bobby Bonilla over $1 million dollars. 

The 57 years old Bonilla last played for the Mets in 1999 and last played baseball in 2001. 

In 2000 the Mets bought out the remaining $5.9 million dollars on Bonilla's contract. The buyout included an 8% negotiated interest rate, meaning the Mets will make payments of just over 1.1 Million dollars for 25 years. During this negotiation, the Mets were advised by Bernie Madoff.

Coronavirus Testing Accuracy Issues

The accuracy of the coronavirus test given to members of the PGA tour has been questioned after PGA pro Cameron Champ withdrew from the Travelers Championship after a positive test. 

Five days later, Champ tested negative three times. Champ said via Twitter that he does not have any symptoms. 

PGA Tour Spokeswoman Laura Neal said, 

"An initial positive is a positive test, and there is a medical explanation of what happens from there... Basically, given the accuracy percentage of the testing process we’re using, we’re confident the person has the virus in them and we want to be on the safest side possible,” 

Coronavirus Update 

There are 10.5 million cases of the virus worldwide, with over 512,000 deaths. The U.S. has 2.6 million cases and 127,000 deaths.

The World Health Organization is warning that come countries might have to reimplement interventions, such as lockdowns, to help stop the spread of the coronavirus. 

The director of the WHO noted that countries such as Spain and Italy have been successful in driving back their outbreaks, which were severe earlier in the pandemic, by adhering to a comprehensive public health strategy. This is not the case with several other countries. 

“Some countries who have had success in suppressing transmission who are opening up now may have a setback, may have to implement interventions again, may have to implement these so-called lockdowns again,” said Dr. Maria Van Kerkhove, the head of the WHO’s Emerging Diseases and Zoonosis unit at a news briefing.

“We hope that we won’t have to go into widespread lockdown again. So it’s not too late to act fast.” 

No specific countries were called out at the briefing. 

And finally, Pfizer announced some positive news around its vaccine candidate. No serious adverse effects were reported in the study, Pfizer said. 

The study randomly gave 45 patients one of three doses of the vaccine, or placebo. 12 people got a 10-microgram dose, another 12 got a 30-microgram dose and the final 12 a 100-microgram dose and then nine received a placebo. If regulators ultimately approve the drug, Pfizer said, the two companies plan to manufacture up to 100 million doses by the end of the year, and "at least" another 1.2 billion by the end of 2021.